Galecto Biotech AB

Works in GI & liver · Hematology · Oncology · Respiratory

Galecto Biotech AB is a clinical trial sponsor. It has 1 active clinical trial with 21 planned participants, in GI & liver, Hematology, Oncology and Respiratory. Since 2021 it has completed 4 trials and stopped 2 early.

Trial track record · since 2021

1Active trials21 planned participants
4Completed3 with results posted
2Stopped early33% of finished trials

Pipeline · 1 active trial

StageTrialStatus

Questions about Galecto Biotech AB

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-06.

Approve Suite is not affiliated with Galecto Biotech AB.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.